Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Regulation of PD-L1: a novel role of pro-survival signalling in cancer.

Open access
Chen, J., Jiang, C.C., Jin, L., Zhang, X.D. · 2016 · Annals of Oncology

Abstract

Evasion of immune system is a hallmark of cancer, which enables cancer cells to escape the attack from immune cells. Cancer cells can express many immune inhibitory signalling proteins to cause immune cell dysfunction and apoptosis. One of these inhibitory molecules is programmed death-ligand-1 (PD-L1), which binds to programmed death-1 (PD-1) expressed on T-cells, B-cells, dendritic cells and natural killer T-cells to suppress anti-cancer immunity. Therefore, anti-PD-L1 and anti-PD-1 antibodies have been used for the treatment of cancer, showing promising outcomes. However, only a proportion of patients respond to the treatments. Further understanding of the regulation of PD-L1 expression could be helpful for the improvement of anti-PD-L1 and anti-PD-1 treatments. Studies have shown that PD-L1 expression is regulated by signalling pathways, transcriptional factors and epigenetic factors. In this review, we summarise the recent progress of the regulation of PD-L1 expression in cancer cells and propose a regulatory model for unified explanation. Both PI3K and MAPK pathways are involved in PD-L1 regulation but the downstream molecules that control PD-L1 and cell proliferation may differ. Transcriptional factors hypoxia-inducible factor-1α and signal transducer and activation of transcription-3 act on the promoter of PD-L1 to regulate its expression. In addition, microRNAs including miR-570, miR-513, miR-197, miR-34a and miR-200 negatively regulate PD-L1. Clinically, it could increase treatment efficacy of targeted therapy by choosing those molecules that control both PD-L1 expression and cell proliferation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdv615

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 1

  1. Junjun, 2013, Detection of soluble B7-H4 molecules in serum of patients with breast cancer and its clinical significance, J Int Transl Med, 1, 215

Cited by

See all 767

Metadata

Authors
Chen, J., Jiang, C. C., Jin, L., & Zhang, X. D.
Affiliations
  • The University of Queensland (AU)
  • University of Newcastle Australia (AU)
Corresponding author
Zhang, X.D.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2016-03
Volume
27
Issue
3
Pages
409-416
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2253000935
Cited by
767
References
102
Citations by year
2026: 31 · 2025: 49 · 2024: 73 · 2023: 82 · 2022: 77 · 2021: 112 · 2020: 105 · 2019: 72 · 2018: 72 · 2017: 61 · 2016: 31
FWCI
5.88
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Funders
NHMRC project (APP1083496)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
PD-L1, PD-1, immune evasion, cancer immunotherapy, PI3K signaling, MAPK signaling, hypoxia-inducible factor-1α, STAT3, transcriptional regulation, epigenetic regulation, microRNA, miR-34a, miR-200 family, cell proliferation, anti-PD-1
MeSH terms
B-Lymphocytes, Dendritic Cells, Humans, Neoplasms, Promoter Regions, Genetic, Protein Binding, T-Lymphocytes, Biomarkers, Tumor, Signal Transduction, NF-kappa B, Tumor Escape, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, MicroRNAs, Cell Proliferation, STAT3 Transcription Factor, Hypoxia-Inducible Factor 1, alpha Subunit, Natural Killer T-Cells, B7-H1 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of PD-L1: a novel role of pro-survival signalling in cancer. https://app.cochat.ai/papers/10.1093/annonc/mdv615
The paper
Chen, J., Jiang, C. C., Jin, L., & Zhang, X. D. (2016). Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Annals of Oncology. https://doi.org/10.1093/annonc/mdv615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.